2017
Aspirin Is Associated with Improved Survival in Severely Thrombocytopenic Cancer Patients with Acute Myocardial Infarction
Feher A, Kampaktsis PN, Parameswaran R, Stein EM, Steingart R, Gupta D. Aspirin Is Associated with Improved Survival in Severely Thrombocytopenic Cancer Patients with Acute Myocardial Infarction. The Oncologist 2017, 22: 213-221. PMID: 28159866, PMCID: PMC5330698, DOI: 10.1634/theoncologist.2016-0110.Peer-Reviewed Original ResearchConceptsAcute myocardial infarctionThrombocytopenic cancer patientsSevere thrombocytopeniaMajor bleedingHematologic malignanciesImproved survivalMyocardial infarctionAspirin useCancer patientsPatient cohortDays of AMIGuideline-recommended medical therapyMemorial Sloan-Kettering Cancer CenterHigh-risk patient cohortTreatment of AMIBenefits of aspirinFatal bleeding eventsOverall patient cohortAspirin therapyBleeding eventsSTP patientsThienopyridine treatmentMedical therapyPlatelet countCancer Center
2016
The effect of in-hospital acquired thrombocytopenia on the outcome of patients with acute coronary syndromes: A systematic review and meta-analysis
Oikonomou EK, Repanas TI, Papanastasiou C, Kokkinidis DG, Miligkos M, Feher A, Gupta D, Kampaktsis PN. The effect of in-hospital acquired thrombocytopenia on the outcome of patients with acute coronary syndromes: A systematic review and meta-analysis. Thrombosis Research 2016, 147: 64-71. PMID: 27689317, PMCID: PMC5515466, DOI: 10.1016/j.thromres.2016.09.026.Peer-Reviewed Original ResearchConceptsAcute coronary syndromeNew onset thrombocytopeniaACS patientsCoronary syndromePlatelet countHigh riskSystematic reviewLong-term adverse eventsHospital heart failureSecondary cardiovascular endpointsMajor bleeding eventsOutcomes of patientsRecurrent myocardial infarctionAbnormal platelet countDevelopment of thrombocytopeniaShort-term mortalityLong-term outcomesNormal platelet countBleeding eventsHospital thrombocytopeniaLate deathsUnplanned revascularizationHospital stayAdverse eventsCardiovascular endpoints